Skip to main content

Heidmar Maritime Holdings Corp. Reports Results for the Second Quarter Ended June 30, 2026

ATHENS, Greece and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) — Heidmar Maritime Holdings Corp. (the “Company” or “Heidmar”) (NASDAQ: HMR) today reported its results for the quarter and six month period ended June 30, 2026. Second Quarter 2026 HighlightsTotal revenues of $29.0 million, up from $9.6 million in Q2 2025 and up $10.6 million from Q1 2026.Net income attributable to shareholders of $2.2 million or $0.04 income per share, basic.Adjusted net income of $2.4 million, which excludes $0.2 million in non-cash stock-based compensation.Cash and cash equivalents of $28.7 million as of June 30, 2026.Adjusted net income is not a measurement recognized under U.S. GAAP (GAAP) and should not be used in isolation or as a substitute for Heidmar’s financial results presented in accordance with GAAP. See...

Continue reading

NIO Inc. Reports Unaudited Second Quarter 2026 Financial Results

Quarterly Total Revenues Reached RMB32,136.9 Million (US$4,736.4 Million)iQuarterly Vehicle Deliveries Were 107,658 Units SHANGHAI, Sept. 01, 2026 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the second quarter ended June 30, 2026. Operating Highlights for the Second Quarter of 2026Vehicle deliveries were 107,658 in the second quarter of 2026, representing an increase of 49.4% from the second quarter of 2025, and an increase of 29.0% from the first quarter of 2026. The deliveries consisted of 60,945 vehicles from NIO brand, 29,124 vehicles from ONVO brand, and 17,589 vehicles from FIREFLY brand.Key Operating Results       2026 Q2 2026 Q1 2025 Q4 2025...

Continue reading

Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2025/2026 financial year

MANAGEMENT COMMENTARYPRFoods’ fourth quarter of the financial year continued to be affected by a challenging economic environment, characterised by weak consumer demand, price pressure and uncertainty in the retail sector. Management remained focused on stabilising operations and implementing the restructuring plan. Fourth‑quarter revenue amounted to EUR 3.4 million, a decrease of 8% compared to the same period last year. Gross profit declined to EUR 0.4 million, mainly due to lower production volumes in the Estonian production unit and volatility in raw material prices. EBITDA improved year‑on‑year by EUR 0.1 million and totalled EUR ‑0.3 million. Operating loss amounted to EUR ‑0.6 million, which is EUR 0.2 million better than in the same period last year. Net profit for the quarter was EUR 0.1 million, but the result was significantly...

Continue reading

Argo Reports Q2 2026 Results: 680% Revenue Growth

Revenue increases 680% to $2.9 million; operating loss declines 79% year-over-yearTORONTO, Aug. 31, 2026 (GLOBE NEWSWIRE) — Argo Corporation (TSXV: ARGH) (OTCQX: ARGHF) (“Argo” or the “Company”), a leader in next-generation public transit solutions, announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026”). All figures are in Canadian dollars unless otherwise noted. Q2 2026 HighlightsRevenue: Q2 revenue increased 680% to $2.9 million, from $0.4 million in Q2 2025; first-half revenue increased 561% to $5.9 million, from $0.9 million in the first half of 2025. Operating Performance: Q2 operating loss declined 79% to $1.1 million, from $5.3 million in Q2 2025; first-half operating loss declined 72% to $2.3 million, from $8.5 million in the first half of 2025. Net Income: Argo reported a net loss...

Continue reading

YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced its financial results for the six months ended June 30, 2026. Management Commentary“The first half of 2026 marks a historic turning point for YD Bio, highlighted by our transition to bottom-line profitability and a remarkable 315% surge in top-line revenue,” said Dr. Ethan Shen, Chairman and CEO of YD Bio. “This explosive growth is the direct result of our proactive commercial strategies, which successfully expanded our volume footprint with existing customers and secured large-scale orders for key diagnostic and therapeutic assets. While our net income of $6.7 million was propelled by non-cash...

Continue reading

Patagonia Gold Quarter 2 2026 Financial Results

VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its financial results for the quarter ended June 30, 2026 (“Q2 2026”). The financial statements together with the related management’s discussion and analysis are available on the Company’s website and under the Company’s profile on SEDAR+ at www.sedarplus.ca. HighlightsProduced 1,960 gold equivalent ounces(1) and sold 515 gold equivalent ounces(1) in Q2 2026 from the Calcatreu operations. Produced 443 gold equivalent ounces(2) and sold 547 gold equivalent ounces(1) in Q2 2026 from the Cap Oeste residual operations. Generated revenue of US$4.5 million in Q2 2026. Spent approximately US$0.7 million on exploration, including US$0.2 million at Calcatreu and US$0.5 million on projects in Santa Cruz,...

Continue reading

Atlantic Petroleum – Condensed Consolidated Interim Report – 2nd Quarter 2026

Tórshavn, Faroe Islands, 2026-08-31 (GLOBE NEWSWIRE) — P/F Atlantic Petroleum (NASDAQ Copenhagen: ATLA DKK) today posts its 2nd quarter results for 2026. This announcement should be read in conjunction with Atlantic Petroleum’s Condensed Consolidated Interim Report, which is released separately and posted on the Company’s website. Highlights for Q2 2026: G&A cost was DKK 0.8MMOperating loss was DKK 2.7MMNet loss was DKK 2.9MMEarnings per share DKK -0.78Net assets/share-holders equity was DKK -119.6MM Mark T. Højgaard, CEO commented: The first half of 2026 was dominated by the finalisation of the debt restructuring agreement signed with our main creditors on 30 April. Once the outstanding payment to Betri Banki has been transferred, the Group’s total debt will be reduced by DKK 98.3 million — a critical step in strengthening...

Continue reading

Pyxis Tankers Announces Financial Results for the Three & Six Months Ended June 30, 2026

Maroussi, Greece, August 31, 2026 – Pyxis Tankers Inc. (Nasdaq Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or “Pyxis Tankers”), an international diversified shipping company, today announced unaudited results for the three and six months ended June 30, 2026. For the three months ended June 30, 2026, our revenues, net, were $12.1 million, compared to $9.2 million for the same period in 2025. During the second quarter of 2026, our time charter equivalent (“TCE”) revenues were $11.5 million, an increase of $2.7 million, or 30.4%, over the comparable period in 2025. Our net income attributable to common shareholders for the second quarter ended June 30, 2026, was $2.8 million, compared to a net loss of $2.0 million for the same period in 2025. For the second quarter of 2026, net income per common share was $0.27 basic and diluted, compared...

Continue reading

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 financial results after the market closes on Monday, September 14. Management will host a conference call at 4:30 p.m. Eastern Time to discuss financial results. A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website. About KestraKestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com. CONTACT:...

Continue reading

Nordic Fibreboard AS unaudited financial report for the Q2 of 2026

  MANAGEMENT REPORT Nordic Fibreboard AS consolidated net revenue in Q2 2026 was €2.27 million, representing a 21.4% increase compared to the same period of the previous year (Q2 2025: €1.87 million), revenue increased by €397 thousand. The Group’s main business activity is the production and wholesale of fibreboard, which accounted for the vast majority of the Group’s revenue in Q2 2026. The second segment comprises the management of the property located on Suur-Jõe Street in Pärnu. However, following the termination of the lease agreements for the building in August 2024, the revenue generated by this segment is immaterial. Nordic Fibreboard’s consolidated EBITDA in Q2 2026 was negative €225 thousand, with an EBITDA margin of negative 10% (Q2 2025 EBITDA: negative €94 thousand, EBITDA margin: negative 5%). The results...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.